Clarius vs Cleerly
Clarius sells through Buy Now stores and a quote request form. Its buyer is a clinician who scans, such as a primary care physician, an MSK clinic or an obstetric practice, using a wireless probe on a phone or tablet. The AI includes Ejection Fraction AI (K253593, March 2026), Bladder AI, OB AI, Prostate AI and Median Nerve AI, and the vendor marks several tools as available in select markets.
Cleerly's buyer is a cardiology group or radiology department analyzing coronary CTA, and Cleerly Plaque (K261210) was cleared in July 2026. CPT Category I code 75577 took effect in January 2026. Cleerly's press release lists UnitedHealthcare, Cigna, Humana, BCBS Kansas City, Excellus BCBS and EviCore as covering payers, with Aetna joining in January 2026 and requiring an FDA-cleared platform.
The two do not share a purchase decision. One is a probe bought for the bedside, the other software bought for CTA studies.
Radiology · Reviewed November 2, 2026
When to pick each one
Clarius
- Wireless handheld ultrasound with AI during scanning
- Ejection Fraction AI cleared as K253593
- Obstetric, bladder, prostate and median nerve AI
Cleerly
- Coronary CTA plaque and stenosis quantification
- PowerScribe reporting integration
- CPT Category I code 75577 effective January 2026
Score
Each row shows points earned of points available under the published rubric.
Clarius
53of 100
Cleerly
52of 100
| Dimension | Clarius | Cleerly | Difference |
|---|---|---|---|
| FDA clearance | 18 / 18 | 18 / 18 | 0 |
| HIPAA / SOC2 / BAA | 0 / 10 | 0 / 10 | 0 |
| EHR integrations (count) | 0 / 4.2 | 0 / 4.2 | 0 |
| Top-3 EHR coverage (Epic / Oracle / Athena) | 0 / 2.4 | 0 / 2.4 | 0 |
| Peer-reviewed papers | 12.7 / 18.2 | 12.7 / 18.2 | 0 |
| RCT / meta-analysis / systematic review | 7.8 / 7.8 | 3.9 / 7.8 | +3.9 |
| Funding & adoption signal | 3 / 12 | 6 / 12 | -3 |
| Pricing transparency | 2.5 / 5 | 2.5 / 5 | 0 |
| Years in market | 0 / 6 | 0 / 6 | 0 |
Scroll horizontally to see every column.
Pricing
Clarius
| Tier | Monthly | Annual | Notes |
|---|---|---|---|
| Enterprise | n/a | n/a | No public price verified. |
Cleerly
| Tier | Monthly | Annual | Notes |
|---|---|---|---|
| Enterprise | n/a | n/a | No public price. The homepage offers a demo request. |
Evidence
Clarius
FDA decisions
K253593 (opens in new tab)510(k)2026-03-02
Clarius Ejection Fraction AI
K250226 (opens in new tab)510(k)2025-05-08
Clarius Median Nerve AI
K243853 (opens in new tab)510(k)2025-04-16
Clarius Prostate AI
K233955 (opens in new tab)510(k)2024-06-14
Clarius OB AI
K232257 (opens in new tab)510(k)2023-11-13
Clarius Bladder AI
Show 1 more
K222406 (opens in new tab)510(k)2023-01-23
Clarius AI
Peer-reviewed
3 PubMed records name Clarius.
- Can handheld ultrasound probes reliably measure transabdominal prostate and bladder volumes? A prospective randomized point-of-care ultrasound study. (opens in new tab)
- Artificial Intelligence-Assisted Lung Ultrasound for Pneumothorax: Diagnostic Accuracy Compared with CT in Emergency and Critical Care. (opens in new tab)
- Validation of Handheld Ultrasound Devices for Point of Care Use in Rheumatology Study- Focus on Synovitis, Doppler Activity, Erosions, and Tendon Lesions. (opens in new tab)
Cleerly
FDA decisions
K260588 (opens in new tab)510(k)2026-07-29
Cleerly LABS
K261210 (opens in new tab)510(k)2026-07-29
Cleerly Plaque
K242338 (opens in new tab)510(k)2025-03-07
Cleerly LABS (v2.0)
K231335 (opens in new tab)510(k)2023-09-08
Cleerly ISCHEMIA
K202280 (opens in new tab)510(k)2020-10-02
Cleerly Labs v2.0
Show 1 more
K190868 (opens in new tab)510(k)2019-11-05
Cleerly Labs
Peer-reviewed
2 PubMed records name Cleerly.
Compliance and integrations
Documented from each vendor’s own pages.
| Spec | Clarius | Cleerly |
|---|---|---|
| Free tier | ||
| HIPAA | ||
| SOC 2 Type II | ||
| EHR integrations | Not specified | Not specified |
| Founded | n/a | n/a |
| HQ | n/a | US |
Scroll horizontally to see both columns.
Common questions
Open the full radiology comparison
Acute-care triage, mammography screening, CCTA plaque analysis, mobile MRI. 30+ FDA-cleared platforms across stroke, oncology, cardiac. Enterprise sales only — we compared what's deployed where.